Personality-Based Therapy for Borderline Personality Disorder
What You Need to Know Before You Apply
What is the purpose of this trial?
Participants with borderline personality disorder will undergo an a 2 - 4 week baseline assessment to determine level of outcomes of interest in the absence of treatment. After the baseline period, participants will receive six weekly 50-60-minute treatment sessions. After the 6 treatment sessions, participants will complete a 4-week follow-up period to determine the sustainability of the treatment module.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications, but it mentions 'medication instability' as an exclusion criterion, which might mean your medication needs to be stable before joining.
Is Personality-Based Therapy safe for humans?
Personality-Based Therapy, including Dialectical Behavior Therapy (DBT) and Mentalization-Based Therapy (MBT), is widely used and considered safe for treating borderline personality disorder. These therapies are evidence-based and have been implemented in various settings, indicating their general safety in humans.12345
How is Personality-Based Therapy different from other treatments for borderline personality disorder?
Personality-Based Therapy for borderline personality disorder is unique because it combines several evidence-based treatments like Dialectical Behavior Therapy (DBT) and Mentalization-Based Therapy (MBT), which focus on improving emotional regulation and understanding others' perspectives. This approach is distinct in its comprehensive integration of multiple therapeutic techniques tailored to individual needs, unlike standard treatments that may focus on a single method.14678
What data supports the effectiveness of the treatment Personality-Based Therapy for Borderline Personality Disorder?
Who Is on the Research Team?
Shannon Sauer-Zavala, PhD
Principal Investigator
University of Kentucky
Are You a Good Fit for This Trial?
This trial is for English-speaking individuals diagnosed with Borderline Personality Disorder. It's not suitable for those who have other psychological conditions needing different treatments, are currently in psychotherapy, have substance use disorders, or whose medication use isn't stable.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants undergo a 2-4 week baseline assessment to determine level of outcomes of interest in the absence of treatment
Treatment
Participants receive six weekly 50-60-minute treatment sessions tailored to 1 of 3 personality dimensions
Follow-up
Participants are monitored for sustainability of the treatment module after the treatment sessions
What Are the Treatments Tested in This Trial?
Interventions
- Personality-Based Therapy
Personality-Based Therapy is already approved in United States, European Union, Canada for the following indications:
Find a Clinic Near You
Who Is Running the Clinical Trial?
Shannon E. Sauer-Zavala
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
American Psychological Foundation
Collaborator